Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Cabaletta Bio
Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
July 02, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
June 14, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 13, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 21, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
March 20, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Upcoming Investor Conferences in March
February 27, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
February 01, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
January 31, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic Sclerosis
January 08, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 28, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis
November 06, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November
October 30, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201
October 02, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
September 19, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
August 30, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
August 22, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
July 24, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares
May 22, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Pricing of Public Offering of Common Stock
May 17, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Proposed Public Offering of Common Stock
May 17, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
May 16, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
May 02, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201
May 01, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit